122 related articles for article (PubMed ID: 38487855)
1. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data.
Tran C; Dinh P
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38487855
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
3. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
5. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database.
Lin S; Wu J; Chen B; Li S; Huang H
Front Endocrinol (Lausanne); 2022; 13():844218. PubMed ID: 35620387
[TBL] [Abstract][Full Text] [Related]
7. Construction of a Potential Breast Cancer-Related miRNA-mRNA Regulatory Network.
Liu X; Chen F; Tan F; Li F; Yi R; Yang D; Zhao X
Biomed Res Int; 2020; 2020():6149174. PubMed ID: 33204705
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
9. Novel MicroRNA Biomarkers for Colorectal Cancer Early Diagnosis and 5-Fluorouracil Chemotherapy Resistance but Not Prognosis: A Study from Databases to AI-Assisted Verifications.
Zhang X; Zhang H; Shen B; Sun XF
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32028703
[TBL] [Abstract][Full Text] [Related]
10. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
11. Integrative systematic review meta-analysis and bioinformatics identifies MicroRNA-21 and its target genes as biomarkers for colorectal adenocarcinoma.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Guraya SY; Bendardaf R; Hamoudi R
Int J Surg; 2020 Jan; 73():113-122. PubMed ID: 31756546
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles and potential functions of microRNAs in heart failure patients from the Uyghur population.
Peng X; Zhang K; Yang Z; Jiang L; Nie X; Zuo H; Wang L
Gene; 2023 Sep; 881():147623. PubMed ID: 37423398
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
15. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
Wei L; Yao K; Gan S; Suo Z
Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNAs as non-invasive diagnostic biomarkers for intrahepatic cholestasis of pregnancy.
Zu Y; Guo S; Li G; Gao Q; Wang X; Zhang C; Liu D
Am J Transl Res; 2022; 14(9):6763-6773. PubMed ID: 36247288
[TBL] [Abstract][Full Text] [Related]
17. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis.
Ji Y; Gu J; Zhang H; Xu H
Int J Gen Med; 2023; 16():5703-5718. PubMed ID: 38077476
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis.
Shu X; Chen XX; Kang XD; Ran M; Wang YL; Zhao ZK; Li CX
World J Clin Cases; 2022 Jun; 10(18):5965-5983. PubMed ID: 35949853
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA differential expression profiles and bioinformatics analysis of hsa_circRNA_079422 in human endometrial carcinoma.
Li Y; Yang Z; Zeng M; Wang Y; Chen X; Li S; Zhao X; Sun Y
J Obstet Gynaecol; 2023 Dec; 43(2):2228894. PubMed ID: 37408092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
